26
|
Bhattacharjee D, Page S. Hypernatraemia in adults: a clinical review. Acute Med 2010; 9:60-65. [PMID: 21597573] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
Dysnatraemic disorders are becoming more common with increased use of biochemical tests in routine practice. Although hyponatraemia is generally much commoner than hypernatraemia, the latter is found in a variety of clinical situations. This review article aims to explain the approach to assessment and strategies for management of hypernatraemia, complications of its treatment and the steps that can be taken for prevention of recurrence.
Collapse
|
27
|
Page S. Handbook of Zoonoses. Identification and Prevention- By Colville JL and Berryhill DL. Aust Vet J 2008. [DOI: 10.1111/j.1751-0813.2008.00291.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
28
|
Le Hello S, Page S, Garin B. Fluoroquinolone resistance in a clinical isolate of Streptococcus pneumoniae in the South Pacific. Int J Antimicrob Agents 2008; 32:91-2. [PMID: 18495439 DOI: 10.1016/j.ijantimicag.2008.02.015] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2008] [Revised: 02/21/2008] [Accepted: 02/21/2008] [Indexed: 12/01/2022]
|
29
|
Page S, Hope K, Bee P, Burns A. Nurses making a diagnosis of dementia--a potential change in practice? Int J Geriatr Psychiatry 2008; 23:27-33. [PMID: 17487937 DOI: 10.1002/gps.1831] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
OBJECTIVES To compare nurse initial diagnoses following domiciliary visits with subsequent formal multidisciplinary formulation based upon the full possession of investigations, neuropsychological tests and brain imaging. DESIGN Retrospective case note study. SETTING Home-based nurse assessments, secondary care based multidisciplinary memory clinic. PARTICIPANTS Four hundred and four consecutive referrals over an 18-month period. RESULTS One hundred and seventy-five patients (43.3%) were diagnosed by the multi-disciplinary team as having a dementia. Seventy-three (41.5%) were classified as Alzheimer's disease, 81 (46%) of mixed sub-type and 20 (11.4%) of vascular origin. Overall nurse-MDT diagnosis agreement was 0.88 (Kappa = 0.82). Together, two nurses were able to detect dementia with 94% accuracy (Kappa = 0.88) Sensitivity was 92% and specificity 96%. The positive and negative predictive values of their judgements were 94% and 98% respectively. Nurses were able to sub-diagnose dementia with 86% (kappa = 0.76) accuracy. Multivariate logistic regression modelling showed a MDT dementia diagnosis to be independently and significantly associated with lower scores on the KOLT and total MMSE, and with the absence of biological markers of depression. Nurse dementia diagnoses were associated with lower KOLT scores and the absence of biological depression markers, high past alcohol consumption or a history of hypercholesteraemia. CONCLUSIONS In this study, structured initial assessment by a specialist nurse was shown to be an accurate method of determining a diagnosis of cognitive impairment, when compared with formal MDT judgement. The principal benefit of this approach was that signposting to subsequent care pathways was expedited. Arguably, such distributed responsibility affords a viable option for the future detection of early dementia.
Collapse
|
30
|
Armstrong DS, Arvieux J, Asaturyan R, Averett T, Bailey SL, Batigne G, Beck DH, Beise EJ, Benesch J, Bimbot L, Birchall J, Biselli A, Bosted P, Boukobza E, Breuer H, Carlini R, Carr R, Chant N, Chao YC, Chattopadhyay S, Clark R, Covrig S, Cowley A, Dale D, Davis C, Falk W, Finn JM, Forest T, Franklin G, Furget C, Gaskell D, Grames J, Griffioen KA, Grimm K, Guillon B, Guler H, Hannelius L, Hasty R, Allen AH, Horn T, Johnston K, Jones M, Kammel P, Kazimi R, King PM, Kolarkar A, Korkmaz E, Korsch W, Kox S, Kuhn J, Lachniet J, Lee L, Lenoble J, Liatard E, Liu J, Loupias B, Lung A, Marchand D, Martin JW, McFarlane KW, McKee DW, McKeown RD, Merchez F, Mkrtchyan H, Moffit B, Morlet M, Nakagawa I, Nakahara K, Neveling R, Ong S, Page S, Papavassiliou V, Pate SF, Phillips SK, Pitt ML, Poelker M, Porcelli TA, Quéméner G, Quinn B, Ramsay WD, Rauf AW, Real JS, Roche J, Roos P, Rutledge GA, Secrest J, Simicevic N, Smith GR, Spayde DT, Stepanyan S, Stutzman M, Sulkosky V, Tadevosyan V, Tieulent R, Van de Wiele J, van Oers WTH, Voutier E, Vulcan W, Warren G, Wells SP, Williamson SE, Wood SA, Yan C, Yun J, Zeps V. Transverse beam spin asymmetries in forward-angle elastic electron-proton scattering. PHYSICAL REVIEW LETTERS 2007; 99:092301. [PMID: 17930999 DOI: 10.1103/physrevlett.99.092301] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/11/2007] [Indexed: 05/25/2023]
Abstract
We have measured the beam-normal single-spin asymmetry in elastic scattering of transversely polarized 3 GeV electrons from unpolarized protons at Q2=0.15, 0.25 (GeV/c)2. The results are inconsistent with calculations solely using the elastic nucleon intermediate state and generally agree with calculations with significant inelastic hadronic intermediate state contributions. A(n) provides a direct probe of the imaginary component of the 2gamma exchange amplitude, the complete description of which is important in the interpretation of data from precision electron-scattering experiments.
Collapse
|
31
|
Billiet L, Furman C, Larigauderie G, Copin C, Page S, Fruchart JC, Brand K, Rouis M. Enhanced VDUP-1 gene expression by PPARγ agonist induces apoptosis in human macrophage. J Cell Physiol 2007; 214:183-91. [PMID: 17579352 DOI: 10.1002/jcp.21179] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
The fate and phenotype of lesion macrophages is regulated by cellular oxidative stress. Thioredoxin-1 (Trx-1) plays a major role in the regulation of cellular redox balance, with resultant effects on gene expression and cellular responses including cell growth and death. Trx-1 activity is inhibited by interaction with vitamin D-upregulated protein-1 (VDUP-1). Peroxisome proliferator-activated receptor gamma (PPARgamma) is expressed by human monocyte-derived macrophages (HMDM) and PPARgamma agonism has been reported to decrease expression of inflammatory genes and to promote apoptosis of these cells. To determine whether VDUP-1 may be involved in regulating the effects of PPARgamma agonists in macrophages, we investigated the effect of a synthetic PPARgamma agonist (GW929) on the expression of VDUP-1 in HMDM. GW929 concentration-dependently increased HMDM expression of VDUP-1 (mRNA and protein). Transfection of different fragments of the VDUP-1 promoter as well as gel shift analysis revealed the presence of functional PPARgamma response elements (PPRE) in the promoter. Under conditions in which PPAR agonism altered levels of VDUP-1, caspase-3 activity, and macrophage apoptosis were also elevated. The results suggest that PPARgamma activation stimulates apoptosis in human macrophages by altering the cellular redox balance via regulation of VDUP-1.
Collapse
|
32
|
Barlow S, Renwick AG, Kleiner J, Bridges JW, Busk L, Dybing E, Edler L, Eisenbrand G, Fink-Gremmels J, Knaap A, Kroes R, Liem D, Müller DJG, Page S, Rolland V, Schlatter J, Tritscher A, Tueting W, Würtzen G. Risk assessment of substances that are both genotoxic and carcinogenic. Food Chem Toxicol 2006; 44:1636-50. [PMID: 16891049 DOI: 10.1016/j.fct.2006.06.020] [Citation(s) in RCA: 119] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2006] [Accepted: 06/26/2006] [Indexed: 11/26/2022]
Abstract
The European Food Safety Authority (EFSA) and the World Health Organization (WHO), with the support of the International Life Sciences Institute, European Branch (ILSI Europe), organized an international conference on 16-18 November 2005 to discuss how regulatory and advisory bodies evaluate the potential risks of the presence in food of substances that are both genotoxic and carcinogenic. The objectives of the conference were to discuss the possible approaches for risk assessment of such substances, how the approaches may be interpreted and whether they meet the needs of risk managers. ALARA (as low as reasonably achievable) provides advice based solely on hazard identification and does not take into account either potency or human exposure. The use of quantitative low-dose extrapolation of dose-response data from an animal bioassay raises numerous scientific uncertainties related to the selection of mathematical models and extrapolation down to levels of human exposure. There was consensus that the margin of exposure (MOE) was the preferred approach because it is based on the available animal dose-response data, without extrapolation, and on human exposures. The MOE can be used for prioritisation of risk management actions but the conference recognised that it is difficult to interpret it in terms of health risk.
Collapse
|
33
|
|
34
|
Sutcliffe A, Kaur D, Page S, Woodman L, Armour CL, Baraket M, Bradding P, Hughes JM, Brightling CE. Mast cell migration to Th2 stimulated airway smooth muscle from asthmatics. Thorax 2006; 61:657-62. [PMID: 16601090 PMCID: PMC2104682 DOI: 10.1136/thx.2005.056770] [Citation(s) in RCA: 45] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BACKGROUND Mast cell microlocalisation within the airway smooth muscle (ASM) bundle is an important determinant of the asthmatic phenotype. We hypothesised that mast cells migrate towards ASM in response to ASM derived chemokines. METHODS Primary ASM cultures from subjects with and without asthma were stimulated with interleukin (IL)-1beta, IL-4, and IL-13 alone and in combination. Mast cell chemotaxis towards these ASM supernatants was investigated, and the chemotaxins mediating migration by using specific blocking antibodies for stem cell factor (SCF) and the chemokine receptors CCR3, CXCR1, 3 and 4 as well as the Gi inhibitor pertussis toxin and the tyrosine kinase inhibitor genistein were defined. The concentrations of CCL11, CXCL8, CXCL10, TGF-beta, and SCF in the supernatants were measured and the effect of non-asthmatic ASM supernatants on the mast cell chemotactic activity of asthmatic ASM was examined. RESULTS Human lung mast cells and HMC-1 cells migrated towards Th2 stimulated ASM from asthmatics but not non-asthmatics. Mast cell migration was mediated through the combined activation of CCR3 and CXCR1. CCL11 and CXCL8 expression by ASM increased markedly after stimulation, but was similar in those with and without asthma. ASM supernatants from non-asthmatics inhibited mast cell migration towards the asthmatic ASM supernatant. CONCLUSION Th2 stimulated ASM from asthmatics is chemotactic for mast cells. Non-asthmatic ASM releases a mediator or mediators that inhibit mast cell migration towards stimulated asthmatic ASM. Specifically targeting mast cell migration into the ASM bundle may provide a novel treatment for asthma.
Collapse
|
35
|
Geerling G, Page S. Knöcherne Orbitadekompression zur Exophthalmuskorrektur bei endokriner Orbitopathie. Klin Monbl Augenheilkd 2005. [DOI: 10.1055/s-2005-922284] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
36
|
|
37
|
Armstrong DS, Arvieux J, Asaturyan R, Averett T, Bailey SL, Batigne G, Beck DH, Beise EJ, Benesch J, Bimbot L, Birchall J, Biselli A, Bosted P, Boukobza E, Breuer H, Carlini R, Carr R, Chant N, Chao YC, Chattopadhyay S, Clark R, Covrig S, Cowley A, Dale D, Davis C, Falk W, Finn JM, Forest T, Franklin G, Furget C, Gaskell D, Grames J, Griffioen KA, Grimm K, Guillon B, Guler H, Hannelius L, Hasty R, Hawthorne Allen A, Horn T, Johnston K, Jones M, Kammel P, Kazimi R, King PM, Kolarkar A, Korkmaz E, Korsch W, Kox S, Kuhn J, Lachniet J, Lee L, Lenoble J, Liatard E, Liu J, Loupias B, Lung A, MacLachlan GA, Marchand D, Martin JW, McFarlane KW, McKee DW, McKeown RD, Merchez F, Mkrtchyan H, Moffit B, Morlet M, Nakagawa I, Nakahara K, Nakos M, Neveling R, Niccolai S, Ong S, Page S, Papavassiliou V, Pate SF, Phillips SK, Pitt ML, Poelker M, Porcelli TA, Quéméner G, Quinn B, Ramsay WD, Rauf AW, Real JS, Roche J, Roos P, Rutledge GA, Secrest J, Simicevic N, Smith GR, Spayde DT, Stepanyan S, Stutzman M, Sulkosky V, Tadevosyan V, Tieulent R, van de Wiele J, van Oers W, Voutier E, Vulcan W, Warren G, Wells SP, Williamson SE, Wood SA, Yan C, Yun J, Zeps V. Strange-quark contributions to parity-violating asymmetries in the forward g0 electron-proton scattering experiment. PHYSICAL REVIEW LETTERS 2005; 95:092001. [PMID: 16197209 DOI: 10.1103/physrevlett.95.092001] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/17/2005] [Indexed: 05/04/2023]
Abstract
We have measured parity-violating asymmetries in elastic electron-proton scattering over the range of momentum transfers 0.12 < or =Q2 < or =1.0 GeV2. These asymmetries, arising from interference of the electromagnetic and neutral weak interactions, are sensitive to strange-quark contributions to the currents of the proton. The measurements were made at Jefferson Laboratory using a toroidal spectrometer to detect the recoiling protons from a liquid hydrogen target. The results indicate nonzero, Q2 dependent, strange-quark contributions and provide new information beyond that obtained in previous experiments.
Collapse
|
38
|
Purandare N, Bloom C, Page S, Morris J, Burns A. The effect of anticholinesterases on personality changes in Alzheimer's disease. Aging Ment Health 2002; 6:350-4. [PMID: 12425769 DOI: 10.1080/1360786021000006974] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
Anticholinesterases are known to be effective against cognitive and non-cognitive symptoms of Alzheimer's disease (AD) but their effect on the personality changes in the disease is not known. This study examines the effect of anticholinesterase treatment on personality changes in AD. It involved the carers of patients with mild to moderate AD who were currently receiving anticholinesterases in south Manchester. The personality change was measured using the Brooks and McKinlay Personality Inventory. The carers were asked to complete the inventory for each of three periods in the patients' lives: before the onset of AD, after the diagnosis of AD but before starting anticholinesterases, and currently on anticholinesterases. Fifty-eight carers participated in the study. Personality became more negative (total score on the personality inventory became less) following the onset of AD (p < 0.001). Following anticholinesterase treatment, the total score on the personality inventory remained the same or increased in 23 (39%) patients. Scores on individual personality traits remained the same or increased in the majority of patients. In approximately one fifth of the patients, the traits 'does things himself', 'happy', 'calm' and 'cautious' showed improvement on anticholinesterases. The study confirms that personality changes are almost universal and negative in AD and suggests that anticholinesterases may have a positive effect. Further double blind prospective studies are needed to understand natural progression of personality changes in AD and to validate the findings of this study.
Collapse
|
39
|
Baumgartner B, Weber M, Quirling M, Fischer C, Page S, Adam M, Von Schilling C, Waterhouse C, Schmid C, Neumeier D, Brand K. Increased IkappaB kinase activity is associated with activated NF-kappaB in acute myeloid blasts. Leukemia 2002; 16:2062-71. [PMID: 12357358 DOI: 10.1038/sj.leu.2402641] [Citation(s) in RCA: 64] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2001] [Accepted: 05/06/2002] [Indexed: 11/09/2022]
Abstract
NF-kappaB/Rel transcription factors are modulators of immune and inflammatory processes and are also involved in malignancy. Phosphorylation of the IkappaB inhibitors by the IkappaB kinase (IKK) complex leads to their proteasomal degradation, resulting in activated NF-kappaB. Here, we investigated the activation status of NF-kappaB and the IKK complex in acute myeloid leukemia (AML). Gelshift assays revealed an increased level of activated nuclear NF-kappaB in myeloid blasts. Both bone marrow and peripheral blood blasts from AML patients showed enhanced IKK activity relative to controls, whereas the IKK protein concentrations were comparable. In addition, an increased level of IkappaB-alpha was detected in AML blast cells, although this appeared to be insufficient to block nuclear translocation of NF-kappaB, also confirmed by immunofluorescence. In subtype M4 and M5 AML cells a more extensive NF-kappaB activation and higher IKK activity was found than in M1/M2 specimens. Isolated AML blasts cultured ex vivo responded to external stimulation (TNF, LPS) by further IKK activation, IkappaB degradation and NF-kappaB activation. Preincubation with the proteasome inhibitor PSI inhibited the NF-kappaB system in isolated AML blasts. This study established for the first time a dysregulation of IKK signaling in AML leading to increased NF-kappaB activity suggesting potential therapeutic avenues.
Collapse
|
40
|
Page S, Ammit AJ, Black JL, Armour CL. Human mast cell and airway smooth muscle cell interactions: implications for asthma. Am J Physiol Lung Cell Mol Physiol 2001; 281:L1313-23. [PMID: 11704524 DOI: 10.1152/ajplung.2001.281.6.l1313] [Citation(s) in RCA: 82] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Asthma is characterized by inflammation, hyperresponsiveness, and remodeling of the airway. Human mast cells (HMCs) play a central role in all of these changes by releasing mediators that cause exaggerated bronchoconstriction, induce human airway smooth muscle (HASM) cell proliferation, and recruit and activate inflammatory cells. Moreover, the number of HMCs present on asthmatic HASM is increased compared with that on nonasthmatic HASM. HASM cells also have the potential to actively participate in the inflammatory process by synthesizing cytokines and chemokines and expressing surface molecules, which have the capacity to perpetuate the inflammatory mechanisms present in asthma. This review specifically examines how the mediators of HMCs have the capacity to modulate many functions of HASM; how the synthetic function of HASM, particularly through the release and expression of stem cell factor, has the potential to influence HMC number and activation in an extraordinarily potent and proinflammatory manner; and how these interactions between HMCs and HASM have potential consequences for airway structure and inflammation relevant to the disease process of asthma.
Collapse
|
41
|
Erali M, Page S, Reimer LG, Hillyard DR. Human immunodeficiency virus type 1 drug resistance testing: a comparison of three sequence-based methods. J Clin Microbiol 2001; 39:2157-65. [PMID: 11376051 PMCID: PMC88105 DOI: 10.1128/jcm.39.6.2157-2165.2001] [Citation(s) in RCA: 50] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
The use of genotypic assays for determining drug resistance in human immunodeficiency virus (HIV) type 1 (HIV-1)-infected patients is increasing. These tests lack standardization and validation. The aim of this study was to evaluate several tests used for the determination of HIV-1 drug resistance. Two genotypic tests, the Visible Genetics TruGene HIV-1 Genotyping Kit and the Applied Biosystems HIV Genotyping System, were compared using 22 clinical samples. Genotyping results were also obtained from an independent reference laboratory. The Visible Genetics and Applied Biosystems genotyping tests identified similar mutations when differences in the drug databases and reference strains were taken into account, and 19 of 21 samples were equivalent. The concordance between the two assays was 99% (249 of 252 mutation sites). Mutations identified by the reference laboratory varied the most among those identified by the three genotypic tests, possibly because of differences in the databases. The concordance of the reference laboratory results with the results of the other two assays was 80% (201 of 252). Samples with 500 to 750 HIV RNA copies/ml could be sequenced by the Visible Genetics and Applied Biosystems assays using 1 ml of input. The Visible Genetics and Applied Biosystems assays both generated an accurate sequence. However, the throughput of the Visible Genetics assay is more limited and may require additional instruments. The two assays differ technically but are similar in overall complexity. Data analysis in the two assays is straightforward, but only the reports provided by Visible Genetics contain information relating mutations to drug resistance. HIV drug resistance genotyping by sequencing is a complex technology which presents a challenge for analysis, interpretation, and reporting.
Collapse
|
42
|
Bentley T, Page S, Meyer D, Chalmers D, Laird I. How safe is adventure tourism in New Zealand? An exploratory analysis. APPLIED ERGONOMICS 2001; 32:327-338. [PMID: 11461034 DOI: 10.1016/s0003-6870(01)00011-4] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
The paper reports findings from a multidisciplinary programme of research, the major aims of which were to determine the nature and extent of the New Zealand adventure tourism injury problem. Analysis of hospital discharge and mortality data for a 15-year period identified adventure tourism-related activities as contributing to approximately 20% of overseas visitor injuries, and 22% of fatalities. Activities that commonly involve independent-unguided adventure tourism, notably mountaineering, skiing and tramping, contributed most to injury and fatality incidence. Horse riding and cycling activities were identified from hospital discharge data and adventure tourism operators' reported client injury-incidence, as the commercial adventure tourism activities most frequently involved in client injuries. Falls were the most common injury events, and a range of client, equipment, environmental and organisational risk factors were identified. Possible interventions to reduce injury risk among overseas and domestic adventure tourists are discussed.
Collapse
|
43
|
Page S, Cramer K. Maclean's rankings of health care indices in Canadian communities, 2000: comparisons and statistical contrivance. CANADIAN JOURNAL OF PUBLIC HEALTH = REVUE CANADIENNE DE SANTE PUBLIQUE 2001; 92:295-8. [PMID: 11962116 PMCID: PMC6979955] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/24/2023]
Abstract
A critical perspective is presented in regard to the 2000 regional rankings of Canadian health care indices by Maclean's magazine, June 5, 2000. This perspective is related in format to previous analyses of the Maclean's rankings of Canadian universities. Several pitfalls in the health care ranking procedures are summarized. The Maclean's data and general criteria appear conceptually reasonable, but their inconsistencies and limited range, together with problems in interpretation of rank data, do not allow them to be logically or empirically useful in the matter of health care evaluation, that is, in the manner portrayed for readers of Maclean's. Using a particular set of parameters defined as health "indicators," the rank data show gratuitously that communities better endowed with certain health services, such as those with medical schools, tend to provide higher levels of care.
Collapse
|
44
|
Page S. Dementia care and cholinesterase inhibitors. PROFESSIONAL NURSE (LONDON, ENGLAND) 2001; 16:1421-4. [PMID: 12026864] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/25/2023]
Abstract
NICE has produced guidance on the use of cholinesterase inhibitors in dementia. ChEIs may postpone the onset of severe symptoms of dementia. Over 80% of people with dementia live in the community and nurses will become increasingly involved in the holistic care of these patients.
Collapse
|
45
|
Page S. Demystifying practice development. NURSING TIMES 2001; 97:36-7. [PMID: 11954429] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/24/2023]
|
46
|
Page S. BOOK REVIEW. Aust Vet J 2001. [DOI: 10.1111/j.1751-0813.2001.tb11986.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
47
|
Dickfeld T, Lengyel E, May AE, Massberg S, Brand K, Page S, Thielen C, Langenbrink K, Gawaz M. Transient interaction of activated platelets with endothelial cells induces expression of monocyte-chemoattractant protein-1 via a p38 mitogen-activated protein kinase mediated pathway. Implications for atherogenesis. Cardiovasc Res 2001; 49:189-99. [PMID: 11121811 DOI: 10.1016/s0008-6363(00)00220-0] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
OBJECTIVE Activated platelets induce alterations of chemotactic and adhesive properties of endothelial cells, a critical initial step in atherogenesis. We investigated the effect of transient interaction of activated platelets with cultured human umbilical vein endothelial cells (HUVECs) on secretion of monocyte chemoattractant protein-1 (MCP-1), a key molecule in monocyte chemotaxis and transmigration. METHODS AND RESULTS Transient interaction of alpha-thrombin-activated platelets with endothelial cells for 10-120 min substantially induced endothelial secretion of MCP-1, monocyte chemotaxis and adhesion to HUVECs. Platelet-induced secretion of MCP-1 and monocyte-endothelium adhesion was reduced by the MAP kinase p38-specific inhibitor SB203580, but not by other kinase inhibitors including PD98059, wortmannin, or rapamycin. In addition, activated platelets induced transcription of a luciferase reporter construct containing a MCP-1 promotor, an effect that could be inhibited by SB203580. Overexpression of dominant-negative mutants of MAP kinase p38, CSBP2-(D168A) and CSBP2-(T180E,Y182E) reduced platelet-induced expression of MCP-1. CONCLUSIONS Activation of the p38 MAP kinase and consecutive endothelial secretion of MCP-1 induced through transient interaction of activated platelets might play an important role in atherogenesis.
Collapse
|
48
|
Tong L, Ang A, Vernon SA, Zambarakji HJ, Bhan A, Sung V, Page S. Sensitivity and specificity of a new scoring system for diabetic macular oedema detection using a confocal laser imaging system. Br J Ophthalmol 2001; 85:34-9. [PMID: 11133709 PMCID: PMC1723671 DOI: 10.1136/bjo.85.1.34] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
AIM To assess the use of the Heidelberg retina tomograph (HRT) in screening for sight threatening diabetic macular oedema in a hospital diabetic clinic, using a new subjective analysis system (SCORE). METHODS 200 eyes of 100 consecutive diabetic patients attending a diabetologist's clinic were studied, all eyes had an acuity of 6/9 or better. All patients underwent clinical examination by an ophthalmologist. Using the HRT, one good scan was obtained for each eye centred on the fovea. A System for Classification and Ordering of Retinal Edema (SCORE) was developed using subjective assessment of the colour map and the reflectivity image. The interobserver agreement of using this method to detect macular oedema was assessed by two observers (ophthalmic trainees) who were familiarized with SCORE by studying standard pictures of eyes not in the study. All scans were graded from 0-6 and test positive cases were defined as having a SCORE value of 0-2. The sensitivity of SCORE was assessed by pooling the data with an additional 88 scans of 88 eyes in order to reduce the confidence interval of the index. RESULTS 12 eyes in eight out of the 100 patients had macular oedema clinically. Three scans in three patients could not be analysed because of poor scan quality. In the additional group of scans 76 out of 88 eyes had macular oedema clinically. The scoring system had a specificity of 99% (95% CI 96-100) and sensitivity of 67% (95% CI 57-76). The predictive value of a negative test was 87% (95% CI 82-99), and that of a positive test was 95% (95% CI 86-99). The mean difference of the SCORE value between two observers was -0.2 (95% CI -0.5 to +0.07). CONCLUSIONS These data suggest that SCORE is potentially useful for detecting diabetic macular oedema in hospital diabetic patients.
Collapse
|
49
|
Page S, Meerabeau L. Achieving change through reflective practice: closing the loop. NURSE EDUCATION TODAY 2000; 20:365-372. [PMID: 10895118 DOI: 10.1054/nedt.2000.0430] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
This paper draws on a small scale, exploratory study which was conducted in the clinical area in the early 1990s (Page 1992). The study drew on the principles of reflective practice in order to enable practitioners to identify learning needs in relation to cardiopulmonary resuscitation (CPR) procedures. Whilst considerable benefit from the reflective sessions was noted, one unanticipated and unpalatable outcome was what might be termed professional apathy. This was manifest in several ways, most importantly in that issues 'for action', identified through reflection, were not prioritised or acted upon. Whilst partial responsibility for this may lie with the somewhat naive way in which the reflective process was facilitated, some responsibility also rests with the nurses in question. One possible explanation is that, for changes in practice to occur, the planning and management of change should form an integral part of the reflective cycle. This point has been largely absent in the reflection literature to date. Such concerns are reviewed here in the context of nurse education's ongoing involvement with the notion of reflective practice and the role of the educationalist in the clinical area. The current political backdrop of 'quality initiatives' to create and demonstrate high standards of clinical care may be useful in advancing the debate.
Collapse
MESH Headings
- Attitude of Health Personnel
- Cardiopulmonary Resuscitation/education
- Cardiopulmonary Resuscitation/nursing
- Clinical Competence
- Decision Making, Organizational
- Education, Nursing, Continuing
- Faculty, Nursing/organization & administration
- Health Knowledge, Attitudes, Practice
- Health Services Needs and Demand
- Humans
- Inservice Training
- Interprofessional Relations
- Models, Educational
- Models, Nursing
- Motivation
- Nurse Administrators/education
- Nurse Administrators/organization & administration
- Nurse Administrators/psychology
- Nurse's Role
- Nursing Education Research
- Nursing Methodology Research
- Nursing Process/organization & administration
- Nursing Staff, Hospital/education
- Nursing Staff, Hospital/organization & administration
- Nursing Staff, Hospital/psychology
- Organizational Innovation
- Philosophy, Nursing
- Social Support
- Thinking
Collapse
|
50
|
Adams T, Page S. New pharmacological treatments for Alzheimer's disease: implications for dementia care nursing. J Adv Nurs 2000; 31:1183-8. [PMID: 10840252 DOI: 10.1046/j.1365-2648.2000.01373.x] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
This paper addresses developments regarding new pharmacological treatments for people with Alzheimer's disease such as Donepezil and Rivastigmine. Following a brief discussion of the experience of people in the early stages of Alzheimer's disease, the pharmacology associated with these new treatments is outlined. The implications of these treatments for nurses working with this client-group are fully discussed within the context of assessment, treatment and cessation. It is argued that nurses have an important contribution in the management of these treatments and recommends that descriptive and evaluative research should be undertaken relating to this new specialist area of nursing care.
Collapse
|